Lanxess falls as Q2 outlook disappoints amid US tariff uncertainty

Shares in Lanxess LXSG.DE fall 4.1% after the German speciality chemicals maker gave a Q2 outlook below market expectations, despite broadly in-line Q1 results and confirmed FY outlook

Lanxess expects Q2 earnings to decline compared to last year, primarily because the earnings contribution from Urethane Systems will no longer be included, it says

"Q1 earnings broadly in line, as Q2 guide appears to be below consensus," J.P.Morgan says

JPM estimates Q2 EBITDA at or below 160 mln euros ($180.5 mln) vs Bloomberg consensus of 170 mln euros, accounting for the sale of the urethanes business, FX headwind and possibly some demand weakness due to tariff-related uncertainty

Lanxess' Q1 EBITDA pre exceptionals was 133 mln euros vs analysts' forecast of 131.6 mln euros in a company-provided poll

The stock, which has gained 6.2% YTD including Thursday's drop, is among the worst performers of Germany's mid-cap index .MDAXI

($1 = 0.8862 euros)